Our recent work on the #metabolic response in #myeloma when treated with a #EZH2 inhibitor is out! nature.com/articles/s4141… #CancerResearch, @UU_University, IGP_UU, Helena J Wiklund Patrick Nylund, PhD

What is known about tertiary lymphoid structures in the central nervous system? Could they be induced or manipulated to fight glioblastoma?💉If you're curious, check out our review on Frontiers - Immunology !🤩 frontiersin.org/articles/10.33…

Following our recent paper: rdcu.be/cy8Wv I am proud to share the publication of our review: One Omics Approach Does Not Rule Them All: The Metabolome and the Epigenome Join Forces in Haematological Malignancies mdpi.com/1303392 #mdpiepigenomes via Epigenomes MDPI

We are proud to share the publication of our review: One Omics Approach Does Not Rule Them All: The Metabolome and the Epigenome Join Forces in Haematological Malignancies mdpi.com/1303392 Epigenomes MDPI @UU_University IGP_UU Helena J Wiklund Patrick Nylund, PhD Berta Garrido-Zabala

So honored to have received the “Best talk prize” from the judges of the 3rd retreat of STorM SciLifeLab 🙏 A great meeting with an even greater network of scientists! Looking forward to the next event 🔬

#coverstory by Antonia Kalushkova et al. (@UU_University): One #Omics Approach Does Not Rule Them All: The Metabolome and the Epigenome Join Forces in Haematological Malignancies mdpi.com/2075-4655/5/4/… #GeneRegulation #MultipleMyeloma

Cancer research takes time and is expensive, but why is it expensive? See our lab featured at #cancerfonden. cancerfonden.se/forskning/pris…

One step closer to developing a successful immunotherapy for brain cancer💪🏻 Absolutely thrilled to see our work published in Cancer Cell, have a read of you’re curious📖 Thanks to my wonderful co-first authors, senior authors and the whole team! Teamwork makes the dream work ♥️

We are so excited to announce that our work on lncRNAs in multiple myeloma has been published in Haematologica   Please find the press release here from Uppsala University here: mynewsdesk.com/uu/pressreleas… Our original article can be found here: doi.org/10.3324/haemat…

New research: The complex nature of lncRNA-mediated chromatin dynamics in multiple myeloma: Extensive genome-wide sequencing efforts have unveiled the intricate regulatory potential of long non-protein coding RNAs (lncRNAs) within the domain of… frontiersin.org/articles/10.33… #oncology

Exciting news 📢 Our newest review is now published in Frontiers - Oncology 📚🔍We're diving deep into the #epitranscriptomics of #lncRNAs and how lncRNAs are involved in #multiplemyeloma pathogenesis. Check it out here: DOI 10.3389/fonc.2023.1303677 tinyurl.com/eu4wezbr

Check it out to know more about #lncRNA #epitranscriptomics and how we should not forget about lncRNAs when investigating #MultipleMyeloma pathogenesis! 📢🔎 Patrick Nylund, PhD as always, it is a pleasure to work together! tinyurl.com/eu4wezbr DOI 10.3389/fonc.2023.1303677

Hit hard and remove treatment – this treatment strategy in Hodgkin Lymphoma promises less fatigue and less sick-leave - ScienceDirect sciencedirect.com/science/articl…

🚨Review Alert!🚨 🌟We're thrilled to unveil our latest review article focusing on the transformative potential of macrophages within the tumor microenvironment in the context of mantle cell lymphoma 🌟 #MantleCellLymphoma #CancerResearch frontiersin.org/journals/immun…

The roles played by macrophages in mantle cell lymphoma, and plans to weaponize them as CAR-macrophages for its treatment, are reviewed by Nylund et al. from Uppsala Univ; tinyurl.com/CAR-Mphage

Last week, I have had the honor to receive the highest degree of education from @UU_University (Sweden): 𝐦𝐲 𝐏𝐡𝐃🎓! What a wonderful day, full of thrilling scientific discussions, fun and love 🔬🎉 . —> see thread! 💕

At #EHA24, please visit our posters #MCL, N=p1243, N=p1274, N=p1118, N=p1129 18.00 Elderly >85 MCL still dies prefarably from their MCL, Long term results Philemon, ibru + lena+R good results Serum profiles identifies macrophages as of interest and genetic of paired biopsies

#EHA24, Acalabrutinib+Bend now for #MCL. Watch out for! #Aplastic anemia triggered by Bruton tyrosine kinase inhibitor acalabrutinib in two pts with mantle cell lymphoma – A case report - Nikkarinen - eJHaem - Wiley Online Library onlinelibrary.wiley.com/doi/10.1002/jh…

#ASH2024 is happening soon and my abstract is already available online! lnkd.in/d6GddSMq Curious about how at the #GlimeliusLab we combined rule-based #machinelearning and #bloodproteomics to identify patients with high risk of early relapse in #MCL? Have sneak peak 👀

Our Phase 1b study in Haematologica shows that triple combination acalabrutinib, bendamustine, and rituximab (ABR) was effective in patients with treatment-naïve or relapsed/refractory #MCL with a similar toxicity as single-agents. tinyurl.com/23v647bd